H.R. 6509

House

SAFE Drugs Act of 2025

In debate

The bill is being debated or has cleared committee and is moving toward a floor vote.

In brief

The Safeguarding Americans from Fraudulent and Experimental Drugs Act of 2025 establishes stricter definitions and reporting requirements for drug compounding, the process where pharmacists or physicians alter medications for specific patients. The bill classifies a compounded drug as a copy of a commercial product if it shares any active ingredients without a medically significant difference, and it increases the number of times such copies can be prescribed to 20 per month. It requires pharmacies and facilities to report data to the Food and Drug Administration (FDA) when shipping these drugs out-of-state and subjects large outsourcing facilities to regular inspections. Introduced by Representative Rudy Yakym (R-IN), the bill is currently referred to a House committee.

Timeline

Every recorded action, oldest first.

May 15, 2025 · House
Introduced
Enhances law enforcement authority to schedule and prosecute the distribution of synthetic drugs. Recently introduced in the House.
Next: Referred to the House Judiciary and Energy and Commerce Committees.
Source
July 26, 2025 · House
Introduced
Addresses synthetic drug distribution through increased law enforcement resources and interdiction authorities.
Next: Referred to the House Judiciary Committee.
Source
July 19, 2026 · House
Introduced
A top-viewed bill in July 2026 focused on addressing drug-related safety and enforcement.
Next: Referred to the House Judiciary Committee.
Source
July 26, 2026 · House
Introduced
This bill increases penalties and enforcement for synthetic drug trafficking. It is currently the third most viewed bill on Congress.gov.
Next: Referred to the House Committee on the Judiciary.
Source
August 2, 2026 · House
Introduced
Addresses drug enforcement and safety regulations. It was the second most viewed bill for the week ending August 2, 2026.
Next: Awaiting committee referral or floor action.
Source
August 9, 2026 · House
Introduced
The SAFE Drugs Act of 2025 aims to enhance federal enforcement against illicit drug trafficking. It was the most-viewed bill on Congress.gov for the week ending August 9, 2026.
Next: Referred to the appropriate House committee.
Source
August 16, 2026 · House
Introduced
The SAFE Drugs Act of 2025 was the most-viewed bill for the week of August 16, 2026.
Next: Referred to the appropriate House committee for review.
Source
August 23, 2026 · House
Introduced
A bill to regulate drug safety and enforcement. It is currently the most-viewed bill on Congress.gov as of August 23, 2026.
Next: Referred to the appropriate House committee.
Source
August 30, 2026 · House
Introduced
Introduced to enhance regulations regarding illicit drugs and pharmaceutical tracking.
Next: Referred to House Committee on Energy and Commerce.
Source
September 6, 2026 · House
Introduced
Creates new enforcement protocols for synthetic drugs and increases penalties for illicit distribution. Current status is introduced.
Next: Referred to the House Committee on the Judiciary.
Source
September 13, 2026 · House
Introduced
The SAFE Drugs Act of 2025 appeared as the most-viewed bill for the week of September 13, 2026.
Next: Referred to House committee.
Source
September 20, 2026 · House
Introduced
This bill, titled the SAFE Drugs Act of 2025, appeared as the most-viewed bill for the week ending September 20, 2026.
Next: Referred to committee.
Source
September 27, 2026 · House
Introduced
The SAFE Drugs Act of 2025 seeks to strengthen federal oversight of controlled substance distribution to combat the opioid crisis.
Next: Referred to House committee.
Source
October 4, 2026 · House
Introduced
The SAFE Drugs Act of 2025 was the most-viewed bill for the week of October 4, 2026, focusing on controlled substance regulations and enforcement.
Next: Referred to the appropriate House committee for further review.
Source
October 11, 2026 · House
Debated
Establishes safety and transparency standards for drug manufacturing; currently a top-viewed bill.
Next: Awaits further action in the House.
Source
October 11, 2026 · House
Introduced
The SAFE Drugs Act of 2025 aims to enhance drug safety protocols and was the most viewed bill for the week of October 11, 2026.
Next: Referred to the appropriate House committee.
Source
October 18, 2026 · House
Introduced
The SAFE Drugs Act of 2025 led the most-viewed bills list for the week of October 18, 2026.
Next: Referred to House committee.
Source
October 18, 2026 · House
Debated
Ranked as the #1 most-viewed bill for the week of October 18, 2026.
Next: Awaits further action in the House.
Source
October 25, 2026 · House
Introduced
Establishes stricter regulations and penalties for synthetic drug trafficking and manufacture.
Next: Referred to House committee for further consideration.
Source
November 1, 2026 · House
Introduced
Establishes stricter regulations for controlled substances and increases penalties for illicit drug distribution; currently a top-viewed bill.
Next: Referred to House committee.
Source